Edition:
United Kingdom

Akari Therapeutics PLC (AKTX.OQ)

AKTX.OQ on NASDAQ Stock Exchange Capital Market

4.00USD
24 Apr 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$4.00
Open
$3.73
Day's High
$4.00
Day's Low
$3.70
Volume
143,242
Avg. Vol
389,506
52-wk High
$9.19
52-wk Low
$1.56

About

Akari Therapeutics, Plc, formerly Celsus Therapeutics Plc, is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of treatments for a range of rare and orphan autoimmune and inflammatory diseases caused by dysregulation of complement component 5 (C5), including paroxysmal nocturnal... (more)

Overall

Beta: -8.40
Market Cap(Mil.): $71.13
Shares Outstanding(Mil.): 0.12
Dividend: --
Yield (%): --

Financials

  AKTX.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -1.84 -- --
ROI: -68.01 8.91 13.83
ROE: -68.13 10.06 15.25

Earnings vs. Estimates